The U.S. Food and Drug Administration (FDA) is issuing a draft notice for market research to inform planning for its Sentinel 3.0 program. It describes a potential three-contract structure, with this notice specifically seeking information on the commercial capability to support Contract 1: a Data Broker to acquire, license, govern, and provide access to multiple types of healthcare data. The services would be performed under a Data Broker-led model where a single prime contractor holds full responsibility for the data. No budget information or location for performance is provided in this description. This is not a solicitation and no award will result from this notice.